207 related articles for article (PubMed ID: 23341181)
1. Prognostic significance of p53 expression in malignant bone tumors: a meta-analysis.
Jiang L; Tao C; He A
Tumour Biol; 2013 Apr; 34(2):1037-43. PubMed ID: 23341181
[TBL] [Abstract][Full Text] [Related]
2. Association of Cytotoxic T-lymphocyte Antigen-4 Polymorphisms with Malignant Bone Tumor Risk: A Meta-analysis.
Zhang C; Hou WH; Ding XX; Wang X; Zhao H; Han XW; Wang WJ
Asian Pac J Cancer Prev; 2016; 17(8):3785-91. PubMed ID: 27644617
[TBL] [Abstract][Full Text] [Related]
3. Effectiveness of Ecteinascidin-743 against drug-sensitive and -resistant bone tumor cells.
Scotlandi K; Perdichizzi S; Manara MC; Serra M; Benini S; Cerisano V; Strammiello R; Mercuri M; Reverter-Branchat G; Faircloth G; D'Incalci M; Picci P
Clin Cancer Res; 2002 Dec; 8(12):3893-903. PubMed ID: 12473605
[TBL] [Abstract][Full Text] [Related]
4. Impact of vascular endothelial growth factor expression on overall survival in patients with osteosarcoma: a meta-analysis.
Zhuang Y; Wei M
Tumour Biol; 2014 Mar; 35(3):1745-9. PubMed ID: 24515658
[TBL] [Abstract][Full Text] [Related]
5. Prognostic significance of serum lactate dehydrogenase levels in Ewing's sarcoma: A meta-analysis.
Li S; Yang Q; Wang H; Wang Z; Zuo D; Cai Z; Hua Y
Mol Clin Oncol; 2016 Dec; 5(6):832-838. PubMed ID: 28105365
[TBL] [Abstract][Full Text] [Related]
6. Overexpression of p53 protein in primary Ewing's sarcoma of bone: relationship to tumour stage, response and prognosis.
Abudu A; Mangham DC; Reynolds GM; Pynsent PB; Tillman RM; Carter SR; Grimer RJ
Br J Cancer; 1999 Mar; 79(7-8):1185-9. PubMed ID: 10098757
[TBL] [Abstract][Full Text] [Related]
7. [Risk factors for pediatric malignant bone tumors].
Ferrís I Tortajada J; Berbel Tornero O; Ortega García JA; Claudio-Morales L; García I Castell J; Martí Perales V; Miranda Casas L
An Pediatr (Barc); 2005 Dec; 63(6):537-47. PubMed ID: 16324620
[TBL] [Abstract][Full Text] [Related]
8. PROGNOSTIC IMPLICATIONS OF PD-L1 EXPRESSION AND LOSS OF PTEN IN PATIENTS WITH RHABDOMYOSARCOMA, EWING'S SARCOMA AND OSTEOSARCOMA.
Abd Elmoneim HM; Huwait HF; Nafady-Hego H; Mohamed FA
Exp Oncol; 2023 Dec; 45(3):337-350. PubMed ID: 38186021
[TBL] [Abstract][Full Text] [Related]
9. Hypoxia and hypoglycaemia in Ewing's sarcoma and osteosarcoma: regulation and phenotypic effects of Hypoxia-Inducible Factor.
Knowles HJ; Schaefer KL; Dirksen U; Athanasou NA
BMC Cancer; 2010 Jul; 10():372. PubMed ID: 20637078
[TBL] [Abstract][Full Text] [Related]
10. Pediatric Malignant Bone Tumors: A Review and Update on Current Challenges, and Emerging Drug Targets.
Jackson TM; Bittman M; Granowetter L
Curr Probl Pediatr Adolesc Health Care; 2016 Jul; 46(7):213-228. PubMed ID: 27265835
[TBL] [Abstract][Full Text] [Related]
11. A systematic review of p53 as a biomarker of survival in patients with osteosarcoma.
Fu HL; Shao L; Wang Q; Jia T; Li M; Yang DP
Tumour Biol; 2013 Dec; 34(6):3817-21. PubMed ID: 24014053
[TBL] [Abstract][Full Text] [Related]
12. p53 and ras mutations in Ewing's sarcoma.
Radig K; Schneider-Stock R; Röse I; Mittler U; Oda Y; Roessner A
Pathol Res Pract; 1998; 194(3):157-62. PubMed ID: 9587933
[TBL] [Abstract][Full Text] [Related]
13. Preclinical evidence that use of TRAIL in Ewing's sarcoma and osteosarcoma therapy inhibits tumor growth, prevents osteolysis, and increases animal survival.
Picarda G; Lamoureux F; Geffroy L; Delepine P; Montier T; Laud K; Tirode F; Delattre O; Heymann D; Rédini F
Clin Cancer Res; 2010 Apr; 16(8):2363-74. PubMed ID: 20371692
[TBL] [Abstract][Full Text] [Related]
14. Association between TP53 rs1042522 gene polymorphism and the risk of malignant bone tumors: a meta-analysis.
Huang X; Wu F; Zhang Z; Shao Z
Biosci Rep; 2019 Mar; 39(3):. PubMed ID: 30833364
[No Abstract] [Full Text] [Related]
15. Etiology of childhood bone cancer: epidemiologic observations.
Miller RW
Recent Results Cancer Res; 1976; (54):50-62. PubMed ID: 1070724
[TBL] [Abstract][Full Text] [Related]
16. Survival outcomes of pediatric osteosarcoma and Ewing's sarcoma: a comparison of surgery type within the SEER database, 1988-2007.
Schrager J; Patzer RE; Mink PJ; Ward KC; Goodman M
J Registry Manag; 2011; 38(3):153-61. PubMed ID: 22223058
[TBL] [Abstract][Full Text] [Related]
17. EWS/Fli-1 chimeric fusion gene upregulates vascular endothelial growth factor-A.
Nagano A; Ohno T; Shimizu K; Hara A; Yamamoto T; Kawai G; Saitou M; Takigami I; Matsuhashi A; Yamada K; Takei Y
Int J Cancer; 2010 Jun; 126(12):2790-8. PubMed ID: 19642105
[TBL] [Abstract][Full Text] [Related]
18. Clinicopathologic significance and prognostic value of circRNAs in osteosarcoma: a systematic review and meta-analysis.
Zhong J; Zhang G; Yao W
J Orthop Surg Res; 2021 Oct; 16(1):578. PubMed ID: 34620208
[TBL] [Abstract][Full Text] [Related]
19. Does serum alkaline phosphatase level really indicate the prognosis in patients with osteosarcoma? A meta-analysis.
Gu R; Sun Y
J Cancer Res Ther; 2018 Jun; 14(Supplement):S468-S472. PubMed ID: 29970708
[TBL] [Abstract][Full Text] [Related]
20. Meta-analysis of clinical significance of p53 protein expression in patients with osteosarcoma.
Wu J; Guo A; Li Q; Wang D
Future Oncol; 2017 Sep; 13(21):1883-1891. PubMed ID: 28766969
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
